FDA’s Rapid Approval of Esketamine Questioned

News: FDA’s Rapid Approval of Esketamine for Severe Depression Questioned   Medscape News Pauline Anderson November 13, 2019 https://www.medscape.com/viewarticle/921248#vp_1 While some experts have hailed intranasal esketamine (Spravato, Janssen) as a “game changer” for treatment-resistant depression (TRD), others are concerned over the US Food and Drug Administration’s (FDA) rapid approval of the drug. In an editorial Read More …

Chronic Pain is a Huge Problem

Chronic pain is a huge problem… It’s time for new approaches. Years of chronic pain take a toll… After 10 agonizing years with chronic pain, Michele S. is in complete remission — free, at least for now, of one of the most chronically painful disorders known to medicine. “I was in constant pain. On a Read More …

Olive’s View of Heaven

Olive’s painting of heaven was for her mother. It was to console her, that Olive was in a “better place”, after her planned suicide.It’s Hard To See Heaven When You Are Hopeless It’s hard to picture heaven if you feel that every day is hell. And unless you have suffered from depression, it’s very hard Read More …